Skip to main navigation

The link is opening in a new window or tab that may or may not accessible Opens an external site Opens an external site in a new window

Pre-Header Contact

800-449-3353 | custserv@rockwellmed.com |

Footer Socials

Pre-Header Menu

Careers | Contact Us

Client Header Links

Home
Our Company
Our Therapeutic Focus
- Iron Deficiency Anemia
- Anemia in Renal Disease
Our Technology
Hemodialysis Concentrates
Investors

Investor Relations

Press Releases

Main navigation

Investor Home
Press Releases
Events & Presentations
Corporate Governance
Management
Annual Meeting
Financial Information
Stock Information
Investor FAQs
Contact Us
Shareholder Tools

Press Releases

Year

Mar 12, 2020

Rockwell Medical, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results

PDF Version

Mar 11, 2020

Rockwell Medical Determines Medical Resource Acquisition Group’s Director Nominations Are Invalid

PDF Version

Mar 10, 2020

Rockwell Medical Acknowledges Receipt of Communications from Medical Resource Acquisition Group

PDF Version

Mar 04, 2020

Rockwell Medical, Inc. to Discuss Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020

PDF Version

Feb 27, 2020

Rockwell Medical, Inc. Provides Business Update

PDF Version

Feb 06, 2020

Rockwell Medical, Inc. to Present at 2020 BIO CEO & Investor Conference

PDF Version

Feb 04, 2020

Rockwell Medical Announces Pricing of $7.5 Million Public Offering of Common Stock

PDF Version

Feb 03, 2020

Rockwell Medical Announces Proposed Public Offering of Common Stock

PDF Version

Jan 14, 2020

Rockwell Medical, Inc. Enters into Exclusive License and Supply Agreements with Sun Pharma for the Rights to Commercialize Triferic® in India

PDF Version

Jan 09, 2020

Rockwell Medical, Inc. Appoints Russell H. Ellison, MD, MSc, to Board of Directors

PDF Version

Pagination

First page
Previous page
Page 1
Current page 2
Page 3
Next page
Last page

Shareholder Tools

Snapshot

Email Alerts

RSS News Feeds

Have any questions?

Phone 248 432-1997

invest@rockwellmed.com

Client Header Links

Home
Our Company
Our Therapeutic Focus
Our Technology
Hemodialysis Concentrates
Investors
Contact

Footer Socials